Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVMD | ALNY | RPRX | ||
| Company | Revolution Medicines Inc | Alnylam Pharmaceuticals | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 189.65 | 316.44 | 57.84 | ||
| High | 192.92 | 320.21 | 58.18 | ||
| Low | 186.56 | 315.35 | 57.34 | ||
| Latest | 189.27 | 319.33 | 58.07 | ||
| Change | -0.72 | +6.29 | +1.15 | ||
| % Change | -0.38% | +2.01% | +2.02% | ||
| Volume | 415,627 | 173,660 | 473,442 | ||
| 20-Day Average Volume | 3,320,132 | 1,227,850 | 3,472,757 | ||
| Previous Close | 189.99 | 313.04 | 56.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 169.17 | 293.85 | 55.29 | ||
| 20-Day Raw Stochastic | 90.41% | 95.14% | 94.66% | ||
| 20-Day Relative Strength | 68.79 | 60.80 | 61.81 | ||
| Weighted Alpha | +204.04 | -8.07 | +68.28 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.05% since 06/29/26 | +8.31% since 06/29/26 | +1.24% since 06/29/26 | ||
| Low | 182.82 on 07/01/26 | 295.18 on 06/30/26 | 55.33 on 07/01/26 | ||
| High | 193.69 on 07/06/26 | 320.20 on 07/07/26 | 58.17 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | +26.44% since 06/05/26 | +4.90% since 06/05/26 | +3.45% since 06/05/26 | ||
| Low | 141.44 on 06/10/26 | 273.11 on 06/18/26 | 51.15 on 06/18/26 | ||
| High | 193.69 on 07/06/26 | 320.20 on 07/07/26 | 58.17 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +95.95% since 04/07/26 | -0.50% since 04/07/26 | +23.32% since 04/07/26 | ||
| Low | 94.63 on 04/10/26 | 273.11 on 06/18/26 | 46.99 on 04/08/26 | ||
| High | 193.69 on 07/06/26 | 343.36 on 04/14/26 | 58.17 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +83.70% since 01/07/26 | -24.76% since 01/07/26 | +39.65% since 01/07/26 | ||
| Low | 91.52 on 03/30/26 | 273.11 on 06/18/26 | 38.86 on 01/20/26 | ||
| High | 193.69 on 07/06/26 | 425.19 on 01/08/26 | 58.17 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,391,116 | 41,794,912 | 32,776,356 | ||
| Shares Outstanding, K | 212,596 | 133,513 | 575,832 | ||
| Annual Sales | 0 | 3,713,940,000 | 2,378,190,000 | ||
| Annual Net Income | -1,131,300,000 | 313,750,000 | 770,950,000 | ||
| Last Quarter Sales | 0 | 1,167,180,000 | 630,580,000 | ||
| Last Quarter Net Income | -453,820,000 | 205,990,000 | 294,690,000 | ||
| 60-Month Beta | 1.37 | 0.27 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.29 on 05/06/26 | 1.99 on 04/30/26 | 1.30 on 05/06/26 | ||
| Earnings Date | 08/05/26 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | 0.235 on 05/15/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 05/15/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 85.69 | 11.39 | ||